Overview

A Randomized Controlled Phase II Clinical Study for Assessing the Efficacy and Safety of BH4 in Radiation Enteritis

Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This present study envisaged a single-center, prospective, open-label, placebo and randomized controlled phase II clinical study to assess the efficacy and Safety of Tetrahydrobiopterin in Treating Radiation Enteritis in Gynecological Cancer Patients.
Phase:
Phase 2
Details
Lead Sponsor:
West China Second University Hospital